Clinical trial
The Pharmacokinetics of Anagrelide in Elderly and Young Patients With Essential…
NCT00413634 · Shire, Industry · Completed
Key facts
| NCT number | NCT00413634 |
|---|---|
| Title | The Pharmacokinetics of Anagrelide in Elderly and Young Patients With Essential Thrombocythaemia (ET) |
| Official title | A Phase II, Open-label, Multicentre, Pharmacokinetic, Pharmacodynamic and Safety Study of Anagrelide Hydrochloride in Young (18-50 Years) and Elderly (≥ 65 Years) Patients With Essential Thrombocythaemia. |
| Lead sponsor | Shire, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Essential Thrombocythaemia |
| Intervention type | Drug |
| Interventions | anagrelide hydrochloride |
| Enrollment | 24 |
| Start date | Nov 13, 2006 |
| Primary completion | Jan 22, 2008 |
| Completion | Jan 22, 2008 |
| First posted | Dec 20, 2006 |
| Last update posted | Jun 29, 2021 |
| Countries | Spain, Sweden, United Kingdom |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: